首页> 外文OA文献 >S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition

【2h】

S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition

机译：3-deazaneplanocin A类似物对S-腺苷同型半胱氨酸水解酶的抑制作用可诱导乳腺癌细胞系产生抗癌作用，并与组蛋白脱乙酰基酶和HER2抑制作用协同作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Hayden, Annette; Johnson, Peter W. M.; Packham, Graham; Crabb, Simon J.;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition [J] . Annette Hayden, Peter W. M. Johnson, Graham Packham, Breast Cancer Research and Treatment . 2011,第1期

机译：3-deazaneplanocin A类似物对S-腺苷同型半胱氨酸水解酶的抑制作用可诱导乳腺癌细胞系产生抗癌作用，并与组蛋白脱乙酰基酶和HER2抑制作用协同作用
2. S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition. [J] . Hayden A, Johnson PW, Packham G, Breast cancer research and treatment. . 2011,第1期

机译：S-腺眼囊肌细胞水解酶抑制3-二聚Zaneplanocin A类似物诱导乳腺癌细胞系中的抗癌作用，以及组蛋白脱乙酰化酶和HER2抑制的协同作用。
3. Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells. [J] . Hodges-Gallagher L, Valentine CD, Bader SE, Breast cancer research and treatment. . 2007,第3期

机译：组蛋白脱乙酰基酶的抑制作用增强了抗雌激素对乳腺癌细胞的抗增殖作用，并阻断了他莫昔芬诱导的子宫细胞增殖。
4. TEA EXTRACTS CONFER ITS ANTIPROLIFERATING EFFECTS THROUGH INHIBITION OF NICOTINE- AND ESTROGEN-INDUCED 9-NICOTINIC ACETYLCHOLINE RECEPTOR UPREGULATION IN HUMAN BREAST CANCER CELLS [C] . Yuan-Soon Ho, Min-Hsiung Pan International Flavor Conference . 2013

机译：茶提取物通过抑制尼古丁和雌激素诱导的9-烟碱乙酰胆碱受体上调在人乳腺癌细胞中赋予其抗增殖效果
5. Synergy of BCL2 and Histone Deacetylase Inhibition against Leukemic Cells from Cutaneous T-cell Lymphoma Patients [D] . Cyrenne, Benoit M. 2018

机译：BCL2和组蛋白去乙酰化酶抑制作用对皮肤T细胞淋巴瘤患者白血病细胞的协同作用
6. Inhibition of phospholipase D2 augments histone deacetylase inhibitor-induced cell death in breast cancer cells [O] . Won Chan Hwang, Dong Woo Kang, Youra Kang, 2020

机译：抑制磷脂酶D2增强组蛋白脱乙酰酶抑制剂诱导的乳腺癌细胞中的细胞死亡
7. Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines [O] . Jan J. Bandolik, Alexandra Hamacher, Christian Schrenk, 2019

机译：I-Moctyone脱乙酰化酶（HDAC）抑制在调节高级浆液癌细胞系中的顺铂效力方面优于泛HDAC抑制
8. Use of Telemorace Inhibition in Combination with Anti-Cancer Drugs to Induce Cell Death in Tumor Cells [R] . Cerone, M. A. 2006

机译：使用Telemorace抑制剂与抗癌药物联合诱导肿瘤细胞死亡

S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅